Strelna, Svyazi st.,
+7 (812) 380 49 33
BIOCAD is one of the largest innovative biotech companies in Russia. The company combines world-class R&D centers and modern pharmaceutical and biotechnological production with preclinical and clinical trials compliant with international standards.
BIOCAD is a full-cycle drug development company, from molecule search to mass production and marketing support. The drugs are intended for the treatment of oncological and autoimmune diseases. The current product portfolio comprises of 61 medical products, with 22 of them being biologics. There are more than 40 products at different stages of development. The research and development of anticancer drugs is one of the priorities of the company.
BIOCAD employs 2600 people, with a third of them being researchers and scientists. The company has several international offices located in Brazil, Vietnam and the UAE.